TRANSHEALTHHUB  BLOG

Youth transition is mostly social, and many transgender young people never take medication.

Systematic reviews gather every eligible study on a question and grade how much confidence the evidence deserves.

The puberty blockers mental health evidence points toward improvement, but study designs cannot prove causation. The largest review to date found better mental health outcomes and called long-term safety uncertain.

Is gender-affirming care evidence-based? U.S. medical and mental-health associations say yes. Several evidence reviews rate parts of the research as low-certainty. Both statements are true, and they answer different questions.

The Cass Review is an independent review of National Health Service (NHS) gender identity services for young people in England, led by Dr. Hilary Cass and published in April 2024.

Supportive care is linked to lower depression scores in the strongest U.S. comparison study to date, with no similar shift in anxiety scores.

Does gender-affirming care reduce suicide risk? Studies consistently link access with lower suicidality, but all are observational, so researchers describe an association, not a proven cause.

The risks of gender-affirming hormones in adolescents sort into three groups: effects that are expected and permanent, effects that are unwanted but manageable, and open questions.

Supportive care for a transgender teen can affect future fertility, and the degree depends on which parts of that care a young person pursues and for how long, according to Mayo Clinic and the Endocrine Society.

Estrogen therapy (also called feminizing hormone therapy) causes predictable physical changes alongside a set of monitored side effects; most reported effects are mild and managed through routine follow-up, according to Mayo Clinic.